Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Reversal of Cognitive Decline (ReCODE) Study
Authors not listed
QuesGen Systems Inc · 2019
Abstract
Prospective study on patients enrolled in the ReCODE treatment protocol
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (2019). Reversal of Cognitive Decline (ReCODE) Study. <em>QuesGen Systems Inc</em>. https://clinicaltrials.gov/study/NCT03883633
Vancouver
Anonymous. Reversal of Cognitive Decline (ReCODE) Study. QuesGen Systems Inc. 2019.
BibTeX
@misc{anon2019Revers,
title = {Reversal of Cognitive Decline (ReCODE) Study},
author = {Anonymous},
journal = {QuesGen Systems Inc},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Hepatology 2021
Preprint · OA
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
Dr. John Muscedere 2019
Open access · US-GOV
Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST) Multi-Center Study
Intensive Care Medicine 2014
Preprint · OA
Prevalence and impact of frailty on mortality in elderly ICU patients: a prospective, multicenter, observational study
Osteoporosis International 2013
Citation only
Frailty and osteoporosis in older women—a prospective study
Neurological Associates of West Los Angeles 2021
Open access · US-GOV
Open Label Study for the Use of Plasmapheresis for Treatment of Age-Related Frailty
National Cheng-Kung University Hospital 2022
Open access · US-GOV